Ex vivo culture of primary human fallopian tube epithelial cells

Journal of Visualized Experiments

Volumn , Issue 51, 2011, Pages

  Fotheringham, Susan ^a,b   Levanon, Keren ^a,b,c   Drapkin, Ronny ^a,b,d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Chaim Sheba Medical Center   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80055103139     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/2728     Document Type: Article

References (12)

1. Jemal, A., Siegel, R., Xu, J. & Ward, E. Cancer statistics, 2010. CA Cancer J. Clin. 60(5), 277-300 (2010).
2. Markman, M. & Walker, J. L. Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment. J. Clin. Oncol. 24(6), 988-994 (2006).
3. Liu, J. & Matulonis, U. A. New advances in ovarian cancer. Oncology (Williston Park). 24(8), 721-728 (2010).
4. Cannistra, S. A. Cancer of the ovary. N. Engl. J. Med. 351(24), 2519-2529 (2004).
5. Kurman, R. J. & Shih, I. M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am. J. Surg. Pathol. 34(3), 433-443 (2010).
6. Fong, M. Y. & Kaka,r S. S. Ovarian cancer mouse models: a summary of current models and their limitations. J Ovarian Res. 2(1), 12 (2009).
7. Shan, W. & Liu, J. Epithelial ovarian cancer: focus on genetics and animal models. Cell Cycle. 8(5), 731-735 (2009).
8. Levanon, K., Crum, C. P. & Drapkin, R. New insights into the pathogenesis of serous ovarian cancer and its clinical impact. J. Clin. Oncol. 26(32), 5284-5293 (2008).
9. Karst, A. M. & Drapkin, R. Ovarian cancer pathogenesis: a model in evolution. J Oncol. 2010, 932371 (2010).
10. Levanon, K., Ng, V., Piao, H. Y., Zhang, Y., Chang, M. C., Roh, M. H., Kindelberger, D. W, Hirsch, M. S., Crum, C. P., Marto, J. A. & Drapkin, R. Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis. Oncogene. 25; 29(8), 1103-1113 (2010).
11. Landen Jr., C. N., Birrer, M. J. & Sood, A. K. Early events in the pathogenesis of epithelial ovarian cancer. J. Clin. Oncol. 26(6), 995-1005 (2008).
12. Vermeer, P. D., Einwalter, L. A., Moninger, T. O., Rokhlina, T., Kern, J. A., Zabner, J. & Welsh, M. J. Segregation of receptor and ligand regulates activation of epithelial growth factor receptor. Nature. 422(6929), 322-326 (2003).